Understanding Value in a
Consumer-Oriented, Patient-Centric Era
An Executive Roundtable Discussion
Thursday, October 15, 2015 | 1:00PM - 5:00PM EST
Edelman | 250 Hudson Street | New York, NY, USA 10013
ORGANIZATIONS REPRESENTED
2 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Allscripts
American Brain Tumor Association
American MedChem Nonprofit Corporation
Americas Health Foundation
Bayer Healthcare
Catalent Pharma Solutions
Center for Healthcare Innovation
Cleveland Clinic
Curant Health
Cystic Fibrosis Foundation
Dohmen Life Science Services
FedEx Services
Fordham University
GE Healthcare
GPIC
Hoboken University Medical Center
Insight Consulting Group
Life Science Leader Magazine
Medgenics
National Osteoporosis Foundation
Openbox
Pall Corporation
Parkland Health & Hospital System
Pfizer
Press Ganey Associates
Quintiles Advisory Services
Spark Therapeutics
Teva Pharmaceuticals
Upsher-Smith Laboratories
WellDoc
Understanding Value in a Consumer-Oriented,
Patient-Centric Era Executive Roundtable
222 S. Riverside Plaza (Suite 1900) | Chicago, IL 60606 | chisite.org | [email protected]
Thursday, October 15, 2015
1:00PM - 5:00PM EST
Edelman
250 Hudson Street
New York, NY, USA 10013
PRESENTED BY
Center for Healthcare Innovation
CHI is an independent, 501(c)(3) research and educational institute that helps pa-tients and providers increase their knowledge and understanding of the op-portunities and challenges of maximizing healthcare value to improve health and quality of life. We aim to make the world a healthier place. CHI encourages and enables meaningful and executable inno-vation that aims to address existing and ensuing healthcare dynamics through communication, education, training, sym-posia, reports, and research. By bringing the best and brightest healthcare leaders from all over the world together to share their ideas and expertise, CHI creates a unique opportunity to address and im-prove healthcare value, which we view as a function of quality, access, and cost.
Understanding What Patient-Centric
Healthcare Value Really Means
Dear Executive Roundtable Attendees,
On behalf of the Center for Healthcare Innovation (CHI), we welcome you to the Understanding Value in a Consumer-Oriented, Patient-Centric Era Roundtable. Today’s Roundtable is an exclusive discussion bringing togeth-er the top thought-leadtogeth-ers, visionaries, and executives from the patient ad-vocate, provider, payer, pharma, biotech, and device sectors to discuss and increase understanding of what patient-centric healthcare value means in the 21st century.
The healthcare landscape has rapidly shifted towards a consumer-driven, patient-centric model of care delivery. Today’s patients have become more empowered in their health and well-being, better informed, and more finan-cially invested than ever before. This paradigm shift has dramatic implica-tions not only for patients, but also for industry as these latter groups at-tempt to define and deliver patient-centric healthcare value. Furthermore, the Roundtable explores the relationship between the definition of value, quality, access, and cost issues. As healthcare costs continue to rise, capi-tation payment models become the new norm, and incentives shift as a re-sult of moving to a value-based healthcare system, understanding and inte-grating patient-centricity into healthcare value will become more important than ever.
We thank you all for joining today’s discussion. We wish you an informative and productive afternoon of learning, and hope you learn new, actionable ideas about patient-centricity that you can take back to your organizations.
Kindest Regards,
Joseph P. Gaspero President & Co-Founder
Agenda
1:00PM
1:30PM
1:35PM
3:00PM
3:30PM
4:45PM
Registration & Networking
Opening Remarks:
Joff Masukawa
1st Roundtable Session
Co-Moderators: Dennis Urbaniak & Rob Wright
Coffee Break & Networking
2nd Roundtable Session
Co-Moderators: Dennis Urbaniak & Rob Wright
Closing Remarks:
Mr. Joff Masukawa
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 5 Mr. Dennis Urbaniak,
Managing Director, Accenture
Co-Moderators
Mr. Dennis Urbaniak is a Managing Director at Accenture. He is a life science and healthcare executive who has demonstrated leadership in driving innovative, customer-centric approaches that result in tangible business results. His areas of expertise include population health, patient services, change management, innova-tion process, executive leadership, customer-centric marketing and sales, and per-formance management. Mr. Urbaniak is also the Chairman and a member of the Center for Healthcare Innovation’s Executive Council since its inception in 2009.
Mr. Rob Wright, Chief Editor, Life Science
Leader Magazine
Mr. Rob Wright is the Chief Editor of Life Science Leader Magazine. Prior to join-ing the publication in this role in 2010, Wright spent nearly 20 years in the pharma-ceutical industry. His experience with companies such as Mead Johnson Nutritionals (formerly a division of Bristol-Myers Squibb), Organon Pharmaceuticals, Schering-Plough, and Merck helps him to provide his readers with credible insights. During his industry career, Wright conducted well over 1,000 presentations and roundtable dis-cussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, co-chaired, moderated and served as a speaker at industry and academic conferences. Wright’s 100+ pub-lished articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a Bachelor of Science (B.S.) in Business Ad-ministration from Indiana University of Pennsylvania, Indiana, PA, and a Master of Business Administration (MBA) with distinction from Gannon University, Erie, PA. He completed his doctoral coursework in marketing at Cleveland State University, Cleveland, OH. During his academic career he was selected as a member of Sigma Beta Delta (International Honor Society for Business, Management, and Administra-tion) and Beta Gamma Sigma (International Honor Society for AACSB accredited business program).
Mr. Joff Masukawa, Board Member, Center for Healthcare Innovation
Opening & Closing Remarks
Mr. Joff Masukawa is President of Diligentia, which develops core business strate-gies, product value, and tactical commercialization requirements for orphan drugs, gene therapy, specialty pharmaceuticals, cell therapy, devices, diagnostics and other novel emerging healthcare products and services. Prior to founding his independent strategic advisory, Joff was Vice President and Global Head of Government Relations and Public Affairs at Shire, where he designed and led strategies to build the compa-ny’s brand, leadership and engagement with governments, patients, payers and other key external stakeholders in existing and emerging markets. Joff has held leadership roles across commercial functions including market access, pricing and reimburse-ment, advocacy and government affairs, patient and provider services, and sales and marketing at Shire, Genzyme, Visible Genetics, Gentiva and LabCorp. He has led and executed many launch strategies for first-in-class products and services and is an ex-pert at enabling optimal legislative, regulatory and market access environments to sup-port business objectives. He began as a clinical sales representative for Merck. Joff is a member of the Board of Directors of the Center for Healthcare Innovation, and a member of the executive committee of the national chapter of the Society of Physician Entrepreneurs.
6 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Executive Participants
Mr. Scott Applebaum, JD
Chief Legal Officer Medgenics
Mr. Jerry Beyl
Vice President of Healthcare Sales FedEx
Dr. Kristine Bordenave, MD
Lead Medical Director Humana
Ms. Patricia Cmielewski, MBA
Chief Marketing Officer Press Ganey Associates
Mr. Robert Coull
Managing Director GPIC
Dr. John Doyle, DrPH
Senior Vice President and Managing Director Quintiles Advisory Services
Ms. Mirona Dragnea, JD
Director, Law & Public Policy Americas Health Foundation
Mr. Patrick Dunham
President & CEO Curant Health
Dr. Lisa Feng, DrPH, MPH
Senior Director, Access Policy + Innovation Cystic Fibrosis Foundation
Dr. Eric Floyd, PhD, MBA
Chief Scientific Officer
Dohmen Life Science Services
Dr. Gregory Gilmet, MD, MPH
Vice President, Medical and Scientific Affairs Upsher-Smith Laboratories
Dr. Anand Iyer, PhD, MBA
Chief Data Science Officer WellDoc
Ms. Theresa Johnson, MBA, MA
Administrator Service Excellence Parkland Health & Hospital System
Mr. Carmen Kestranek, MBA
Senior Director, Office of Patient Experience Cleveland Clinic
Dr. Rivka Kreitman, PhD, MA
SVP, Head of Biologics, Women Health & Autoimmune Global Strategic Marketing Teva Pharmaceuticals
Ms. Therese Little
Director Openbox
Mr. Jeffrey Marrazzo, MBA, MPA
Co-Founder, CEO and Director Spark Therapeutics
Mr. Jerold Martin, MS
Senior Vice President of Global Scientific Affairs
Pall Corporation (Retired)
Ms. Neena Philip
Assistant Vice President of Nursing Services Hoboken University Medical Center
Mr. Matt Portch
Senior Director, Commercial Effectiveness Pfizer
Ms. Susan Randall, MSN
Senior Director, Science and Education National Osteoporosis Foundation
Executive Participants
Ms. Patricia Riskind, MBA
Chief Client Experience Officer Press Ganey Associates
Ms. Vera Rulon, MS
Board of Directors, American Health Information Management Association Foundation
Director, Strategic Communications, External Medical Communications, Pfizer Medical
Mr. Dick Salvatierra, MPA, MA
President
Americas Health Foundation
Dr. Roslyn Schneider, MD, MSc
Global Patient Affairs Lead Pfizer
Dr. Robert Selliah, PhD
Founder, President & CEO
American MedChem Nonprofit Corporation
Dr. Falguni Sen, PhD
Professor
Fordham University
Dr. Cornell Stamoran
Vice President, Strategy & Government Affairs Catalent Pharma Solutions
Dr. Tim Wighton, DrPH
Co-Founder & CEO insight Communication
Ms. Elizabeth Wilson, MNA
President and CEO
American Brain Tumor Association
Mr. Don Woodlock
Senior Vice President and GM, Cardiology IT GE Healthcare
CHI Roundtable Planning Committee
8 Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable
Dr. Cheryl Beal Anderson, PharmD, MBA
Vice-President, Head of Regulatory Affairs at Upsher-Smith Laboratories Member of Board of Directors at CHI
Mr. Joseph Gaspero
President & Co-Founder of CHI
Ms. Lynn Hanessian
Chief Science Strategist at Edelman Member of Board of Directors at CHI
Dr. Kevin Konradt
Project Manager at Allscripts
Mr. Joff Masukawa
President of Diligentia
Member of Board of Directors at CHI
Mr. Douglas Swill, JD
Partner & Chair of Health Care Practice Group at Drinker Biddle & Reath Member of Board of Directors at CHI
Mr. Dennis Urbaniak
Managing Director at Accenture Chairman of Executive Council at CHI
Dr. Eckhard von Keutz
Senior Vice President, Head Global Early Development at Bayer Healthcare Member of Executive Council at CHI
Understanding Healthcare Value in a Consumer-Oriented, Patient-Centric Era Roundtable 9
The Center for Healthcare Innovation is an independent, 501(c)(3) research and educational institute that helps patients and providers increase their knowledge and understanding of the opportunities and challenges of maximizing healthcare value to improve health and quality of life. We aim to make the world a healthier place. CHI encourages and enables meaningful and executable innovation that aims to address existing and ensuing healthcare dynamics through commu-nication, education, training, symposia, reports, and research. By bringing the best and brightest healthcare leaders from all over the world together to share their ideas and expertise, CHI creates a unique opportunity to address and im-prove healthcare value, which we view as a function of quality, access, and cost.
MISSION
OBJECTIVES
INITIATIVES
1. Bring together key stakeholders to develop collaborative relationships to positively impact healthcare value 2. Increase understanding of the definition, framework, and metrics of healthcare value
3. Produce primary, impactful research focused specifically on the interrelationship of healthcare quality, access, & cost
4. Analyze fundamental drivers and trends of rapidly rising healthcare costs
5. Identify and disseminate best practices for optimizing healthcare quality and access
Diversity, Inclusion, & Life Sciences Symposium
Healthcare Executive Roundtable
Patient as an Innovator Educational Workshop
Healthcare Value and the Interrelationship of Quality, Access, and Costs Research Report
Pharmaceutical-ACO Collaboration Research Report
The Value of Sovaldi: Societal Cost Issues of New Interventions on Hepatitis C Research
Unintended Consequences of Healthcare & Life Science Legislation Research Report
Diversity & Inclusion Consulting
The Science Runway: Inspiring Young Girls to Join the Healthcare & Life Sciences Industry
Clinical Research Exchange
CHI LEADERSHIP
BOARD OF DIRECTORS
Mr. Michel Feldman (Chairman), JD, Senior Partner, Seyfarth Shaw
Dr. Cheryl Beal Anderson, PharmD, MBA, Vice-President, Head of Regulatory Affairs at Upsher-Smith
Dr. Benée Brown, PharmD, Senior Medical Science Liaison, Sanofi
Mr. Chris Caruso, MBA, Partner at Deloitte
Dr. James Gillespie, PhD, JD, MPA, Chief Executive Officer, Center for Healthcare Innovation
Mr. Sanjay Kadaveru, Founder and President, Action For India
Ms. Lynn Hanessian, Chief Science Strategist, Edelman
Mr. Joff Masukawa, President, Diligentia
Dr. Andrea Small-Howard, PhD, MBA, Chief Science Officer, GB Sciences
Mr. Douglas Swill, JD, Partner & Chair of Health Care Practice Group at Drinker Biddle & Reath
EXECUTIVE COUNCIL
Mr. Dennis Urbaniak (Chairman), Managing Director, Accenture
Dr. Laurent Audoly (Vice Chairman), Global Head R&D, Pierre Fabre
Dr. Albert Jaramillo, Managing Partner, Workplace International
Mr. Richard Smith, Managing Director, Life Sciences & Specialty Services, FedEx
Dr. Eckhard von Keutz, Senior Vice President, Head Global Early Development, Bayer Healthcare
RESEARCH GROUP
Mr. James Jordan (Chairman), Distinguished Service Professor in Healthcare & Biotechnology Management,
Carnegie Mellon University
Mr. Mark Kwatia (Vice Chairman), Cost Strategy, Abbott Laboratories
Dr. G. Randall Green, Program Director, Cardiac Surgery, St. Joseph’s Hospital Health Center
Dr. Marco Quarta, Director, Inst. for Bioengineering in Stem Cell & Regenerative Medicine, Stanford
Dr. Kate Rosenbluth, CEO, Cala Health
Dr. James Su, Chief Science Officer, Lap IQ
SPECIAL ADVISORS
Mr. Mark Hattas, Founder, Former CEO, & Chairman, Geneca
Dr. Stuart Rich, Professor of Medicine at Northwestern University
MANAGEMENT TEAM
Mr. Joseph Gaspero, President & Co-Founder, Center for Healthcare Innovation
Dr. Sarah Wamala, Swedish National Institute of Public Health
Dr. Tina Shah, Chair-Elect of Resident and Fellow Section, American Medical Association
Ms. Ritu Kamal, Global Project Manager, Biodesign Program, Stanford University
Mr. Joshua Limp, Senior Project Manager, Center for Healthcare Innovation
Ms. Sandra Mumanachit, Senior Consultant at CVS health
Upcoming Research & Education
The Patient as Innovator Educational Workshop
The Patient as Innovator workshop is an educational forum for patients, providers, payers, and policymakers to discuss innova-tive ways to create an earlier intersection between patients and developers of medical technologies in order to deliver a more informed, value-driven approach to the innovation of new medical solutions, technologies, and treatments. In today’s healthcare landscape, patients are dramatically more informed, empowered, and financially invested in their health and well-being than ev-er before. Technology has also made today’s patients as savvy and informed as evev-er. Additionally, providev-ers, payev-ers, and poli-cymakers are faced with rising costs, increasing demand, and other pressures as healthcare transitions to a value-based system. Thus, it is critical to engage key stakeholders and incorporate their perspectives earlier in development phases in order to en-sure that provider organizations deliver healthcare products that are producing maximum value and quality, increasing access, and reducing costs for patients. The Patient as Innovator workshop educates patients, providers, payers, and policymakers on how to create earlier collaboration and incorporate all perspectives into medical innovation.
February 3, 2016 | Washington, DC, USA
chisite.org/education/patient-educational-workshop
Pharmaceutical-ACO Collaboration Research Report
A comprehensive research report examining pharma-ACO collaboration. The U.S. spends more on healthcare than many other industrialized nations while not necessarily matching quality. The ACOs that were created out of the Patient Protection and Affordable Care Act (ACA) were introduced to improve access to quality care while simultaneously reducing costs. As phar-ma, providers, and other healthcare stakeholders move to a value-based system with an emphasis on driving value for the pa-tient, new and innovative partnerships and collaboration will be more important that even. The research report aims to ex-plore pharma-ACO collaboration and other innovative partnership models.
February 2016
chisite.org/research
Best Practices for Implementing Patient-Centric Strategies White Paper
A white paper that examines how to implement patient-centric strategies for providers, pharma, pharmacy, payer, policymak-ers, and other stakeholders. This white paper will feature actionable, pragmatic insights and best practices on how organiza-tions can develop strategies and implement tactics on putting patients at the center of the healthcare equation. The white pa-per will also explore some of the challenges that organizations face in attempting to implement these ideas.
March 2016
chisite.org/research
Diversity, Inclusion, & Life Sciences Symposium
The Diversity, Inclusion, & Life Sciences Symposium is an annual, interactive, collaborative symposium for life sciences and healthcare executives, entrepreneurs, policymakers, researchers, scientists, technologists, academics, and service providers to discuss best practices as well as challenges and opportunities at the crucial interface of diversity, inclusion, and the life sciences industry. The symposium is the world’s preeminent annual conference focused specifically on mutually beneficial collaborations between the life sciences industry and diverse communities. Attendees will gain valuable contacts, connections, knowledge, information, and insights.